HCW Biologics (HCWB) Revenue & Revenue Breakdown
HCW Biologics Revenue Highlights
Latest Revenue (Y)
$2.57M
Latest Revenue (Q)
$15.61K
HCW Biologics Revenue by Period
HCW Biologics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $2.57M | -9.68% |
| 2023-12-31 | $2.84M | -57.72% |
| 2022-12-31 | $6.72M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $4.10M | 100.00% |
| 2019-12-31 | - | - |
HCW Biologics generated $2.57M in revenue during NA 2024, up -9.68% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
HCW Biologics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $15.61K | 138.26% |
| 2025-06-30 | $6.55K | 29.32% |
| 2025-03-31 | $5.07K | -98.72% |
| 2024-12-31 | $394.80K | -7.41% |
| 2024-09-30 | $426.42K | -31.09% |
| 2024-06-30 | $618.85K | -45.07% |
| 2024-03-31 | $1.13M | -14.90% |
| 2023-12-31 | $1.32M | 55.20% |
| 2023-09-30 | $853.10K | 36.98% |
| 2023-06-30 | $622.81K | 1387.02% |
| 2023-03-31 | $41.88K | -96.88% |
| 2022-12-31 | $1.34M | -25.84% |
| 2022-09-30 | $1.81M | 298.46% |
| 2022-06-30 | $454.00K | -85.44% |
| 2022-03-31 | $3.12M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $4.10M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
HCW Biologics generated $15.61K in revenue during Q3 2025, up 138.26% compared to the previous quarter, and up 2.52% compared to the same period a year ago.
HCW Biologics Revenue Breakdown
HCW Biologics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 25 |
|---|---|
| Operating Segments | $5.07K |
Latest
HCW Biologics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Operating Segments (100.00%).
HCW Biologics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HCWB | HCW Biologics | $2.57M | $15.61K |
| BCLI | Brainstorm Cell Therapeutics | $849.00K | - |
| CELZ | Creative Medical Technology | $11.00K | - |
| APRE | Aprea Therapeutics | - | $118.11K |
| ACXP | Acurx Pharmaceuticals | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| ADIL | Adial Pharmaceuticals | - | - |
| INAB | IN8bio | - | - |
| APVO | Aptevo Therapeutics | - | - |
| BCDA | BioCardia | - | - |
| NRSN | NeuroSense Therapeutics | - | - |